Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CGON stock hub

CG Oncology, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CGONis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.1B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CGON

In the news

Latest news · CGON

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROIC-18.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CGON market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

162

Groups with data

Currency

USD

Showing 162 of 162 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001991792
Company name	CG Oncology, Inc.
Country	United States
Country code	US
Cusip	156944100
Employees	142
Employees Change	29%
Employees Change Percent	25.66
Enterprise value	$5.4B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2024-01-25
Isin	US1569441009
Last refreshed	2026-05-10
Market cap	$6.1B
Market cap category	Mid-Cap
Price	$69.62
Price currency	USD
Rev Per Employee	35,711.27x
Sector	Healthcare
Sic	2836
Symbol	CGON
Website	https://cgoncology.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.04%
EV Sales Forward	135.78x
EV/Sales	1,065.97x
P/B ratio	7.46x
P/S ratio	1,210.94x
PS Forward	154.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-119.2M
Net Income	$-186.7M
Net Income Growth Years	0%
Pretax Margin	-3,682.61%
Profit Per Employee	$-1.3M
ROIC	-18.34

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	211.88%
EPS Growth Years	0
Revenue Growth	666.01x
Revenue Growth Q	1,982.69x
Revenue Growth Quarters	3x
Revenue Growth Years	3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	$742.2M
Debt	$7M
Debt Equity	$0.01
Equity	$752.6M
Net Cash	$735.1M
Net Cash By Market Cap	$11.97
Net Cash Growth	6.94%
Net Debt Equity	$-0.98
Tangible Book Value	$741.7M
Tangible Book Value Per Share	$9.19
WACC	6.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-13.77%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	211.64%
200-day SMA	46.91
50-day SMA	66.12
50-day SMA vs 200-day SMA	50over200
All Time High	73.56
All Time High Change	-5.36%
All Time High Date	2026-04-17
All Time Low	14.8
All Time Low Change	370.41%
All Time Low Date	2025-04-09
ATR	2.85
Beta	0.42
Beta1y	0.69
Beta2y	1.62
Ch YTD	67.68
High	70.32
High52	73.56
High52 Date	2026-04-17
High52ch	-5.36%
Low	68.55
Low52	21.9
Low52 Date	2025-05-08
Low52ch	217.9%
Ma50ch	5.29%
Premarket Change Percent	-0.12
Premarket Price	$69.1
Premarket Volume	10,003
Price vs 200-day SMA	48.41%
RSI	56.92
RSI Monthly	75.21
RSI Weekly	70.01
Sharpe ratio	2.21x
Sortino ratio	4.56
Total Return	-13.77%
Tr YTD	67.68
Tr1m	-0.27%
Tr1w	5.06%
Tr3m	38.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	6
Analyst Price Target Top	$82.17
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.55
Earnings Revenue Estimate	512,632x
Earnings Revenue Estimate Growth	885.83x
Operating Income	$-215M
Operating margin	-4,239
Price target	$77.9
Price Target Change	$11.89
Price Target Change Top	$18.03

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	72,616,351%
Float Percent	82.33%
Shares Insiders	0.93%
Shares Institutions	90.57%
Shares Out	88,202,473
Shares Qo Q	5.56%
Shares Yo Y	13.77%
Short Float	13.13%
Short Ratio	6.69
Short Shares	10.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	943,401.4x
Bv Per Share	9.33
Ch1m	-0.27
Ch1w	5.06
Ch1y	211.6
Ch3m	38.25
Ch6m	75.45
Change	0.64%
Change From Open	1.04
Close	69.18
Days Gap	-0.4
Depreciation Amortization	1,782,250
Dollar Volume	79,577,748.6
Earnings Date	2026-05-08
Earnings Time	bmo
EBIT	$-215M
EBITDA	$-213.2M
EPS	$-2.35
F Score	1
Fiscal Year End	December
Founded	2,010
Ipr	266.4
Iprfo	140.1
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-27
Ma150	52.45
Ma150ch	32.75%
Ma20	68.25
Ma20ch	2.01%
Next Earnings Date	2026-08-07
Open	68.9
Optionable	Yes
Position In Range	60.45
Pre Close	69.18
Price Date	2026-05-08
Ptbv Ratio	8.28
Relative Volume	1.21x
Revenue	5,071,000x
Tr6m	75.45%
Us State	California
Volume	1,143,030

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CGON pay a dividend?

Capital-return profile for this ticker.

Performance

CGON stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CGON?

Insider, institutional, and short-interest positioning.

Institutional ownership

+90.6%

Float: +82.3% of shares outstanding

Insider ownership

+0.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CGON momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.9

Neutral momentum band

Price vs 200-day MA

+48.4%

50/200-day relationship not available

Beta (5Y)

0.42

Less volatile than the market

Sharpe ratio

2.21

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CGON

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CGON stock rating?

CG Oncology, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CGON analysis?

The full report lives at /stocks/CGON/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CGON?

The latest report frames CGON around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CGON page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.